Category: Press Release - Page 128 - Psychedelic Alpha

Part 3 of our Year in Review video series is out now.

Read more about the article More than 80% of Americans report one or more symptoms of depression, and many have turned to substances to cope with negative emotions during COVID-19 Pandemic, according to Field Trip Health’s First Annual “State of Mind” Survey

More than 80% of Americans report one or more symptoms of depression, and many have turned to substances to cope with negative emotions during COVID-19 Pandemic, according to Field Trip Health’s First Annual “State of Mind” Survey

Post published:May 18, 2021
Post category:Press Release

Read more about the article Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip

Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip

Post published:May 17, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences Shares to Commence Trading on the OTCQB Venture Market on May 17, 2021

Bright Minds Biosciences Shares to Commence Trading on the OTCQB Venture Market on May 17, 2021

Post published:May 17, 2021
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Receives Positive Feedback from U.S. FDA for Psychedelic Drug DMT Clinical Research Program for Stroke

Algernon Pharmaceuticals Receives Positive Feedback from U.S. FDA for Psychedelic Drug DMT Clinical Research Program for Stroke

Post published:May 17, 2021
Post category:Press Release

Read more about the article PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease

PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease

Post published:May 17, 2021
Post category:Press Release

Read more about the article MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial

MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial

Post published:May 17, 2021
Post category:Press Release

Read more about the article Filament Announces C$10M Offering and Filing of Initial Listing Application

Filament Announces C$10M Offering and Filing of Initial Listing Application

Post published:May 17, 2021
Post category:Press Release

Read more about the article BetterLife Announces Closing of a Non-Brokered Private Placement

BetterLife Announces Closing of a Non-Brokered Private Placement

Post published:May 14, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Corp. Provides Corporate Update

Entheon Biomedical Corp. Provides Corporate Update

Post published:May 14, 2021
Post category:Press Release

Read more about the article MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD ($194m CAD) to Execute on Diverse Clinical Pipeline

MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD ($194m CAD) to Execute on Diverse Clinical Pipeline

Post published:May 14, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.